Richard C Boucher
Overview
Explore the profile of Richard C Boucher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
239
Citations
15705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sims A, Schafer A, Okuda K, Leist S, Kocher J, Cockrell A, et al.
mSphere
. 2025 Jan;
10(2):e0095124.
PMID: 39882872
Coronaviruses (CoV) emerge suddenly from animal reservoirs to cause novel diseases in new hosts. Discovered in 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) is endemic in camels in the...
2.
Joy N, Deshpande A, Lingamallu S, Prabantu V, Naveenkumar C, Bharathkumar K, et al.
bioRxiv
. 2024 Dec;
PMID: 39713474
Airway multiciliated cells (MCs) maintain respiratory health by clearing mucus and trapped particles through the beating of motile cilia. While it is known that ciliary lengths decrease along the proximal-distal...
3.
Clark J, Blake A, Vasher S, Boucher R, Jones A, Choi H, et al.
Gynecol Oncol Rep
. 2024 Sep;
55:101486.
PMID: 39281842
•Mirvetuximab soravtansine-gynx should be recognized as a cause of drug-induced interstitial lung disease (ILD).•Radiographic manifestations of mirvetuximab soravtansine-gyn induced ILD include organizing pneumonia pattern.•Interstitial lung disease related to mirvetuximab soravtansine-gyn...
4.
Sun L, Walls S, Dang H, Quinney N, Sears P, Sadritabrizi T, et al.
bioRxiv
. 2024 Aug;
PMID: 39211176
Rationale: Hyper IgE syndrome (STAT3-HIES), also known as Job's syndrome, is a rare immunodeficiency disease typically caused by dominant-negative STAT3 mutations. STAT3-HIES syndrome is characterized by chronic pulmonary infection and...
5.
Curtis J, Bateman L, Murray S, Couper D, Labaki W, Freeman C, et al.
Chronic Obstr Pulm Dis
. 2024 Aug;
11(5):444-459.
PMID: 39159077
Background: The biological mechanisms leading some tobacco-exposed individuals to develop early-stage chronic obstructive pulmonary disease (COPD) are poorly understood. This knowledge gap hampers development of disease-modifying agents for this prevalent...
6.
Meganck R, Edwards C, Mallory M, Lee R, Dang H, Bailey A, et al.
Cell Rep
. 2024 Apr;
43(4):114076.
PMID: 38607917
The severe acute respiratory syndrome coronavirus 2 pandemic is characterized by the emergence of novel variants of concern (VOCs) that replace ancestral strains. Here, we dissect the complex selective pressures...
7.
Lee-Ferris R, Okuda K, Galiger J, Schworer S, Rogers T, Dang H, et al.
bioRxiv
. 2024 Feb;
PMID: 38370820
In vitro models play a major role in studying airway physiology and disease. However, the native lung's complex tissue architecture and non-epithelial cell lineages are not preserved in these models....
8.
Proximal and Distal Bronchioles Contribute to the Pathogenesis of Non-Cystic Fibrosis Bronchiectasis
Asakura T, Okuda K, Chen G, Dang H, Kato T, Mikami Y, et al.
Am J Respir Crit Care Med
. 2023 Nov;
209(4):374-389.
PMID: 38016030
Non-cystic fibrosis bronchiectasis (NCFB) may originate in bronchiolar regions of the lung. Accordingly, there is a need to characterize the morphology and molecular characteristics of NCFB bronchioles. Test the hypothesis...
9.
Wang S, Niroula S, Hoffman A, Khorrami M, Khorrami M, Yuan F, et al.
Am J Respir Crit Care Med
. 2023 Sep;
208(9):930-943.
PMID: 37695863
CFTR (cystic fibrosis transmembrane conductance regulator) modulator drugs restore function to mutant channels in patients with cystic fibrosis (CF) and lead to improvements in body mass index and lung function....
10.
Nakakubo S, Kishida N, Okuda K, Kamada K, Iwama M, Suzuki M, et al.
Lancet Infect Dis
. 2023 Jul;
23(11):1244-1256.
PMID: 37399831
Background: Previous SARS-CoV-2 infection and vaccination, coupled with the rapid evolution of SARS-CoV-2 variants, have modified COVID-19 clinical manifestations. We aimed to characterise the clinical symptoms of COVID-19 individuals in...